News & Updates
Filter by Specialty:
Show Multimedia Only

Pivotal phase III trial shows Tx potential of oral carbapenem for cUTI or acute pyelonephritis
20 Nov 2025
byAudrey Abella
Results from the phase III PIVOT-PO study demonstrate the potential of tebipenem pivoxil hydrobromide (TBP-PI) as an effective oral carbapenem antibiotic for the treatment of complicated urinary tract infections (cUTI).








